DCPH Stock Summary and Trading Ideas (Deciphera Pharmaceuticals | NASDAQ:DCPH)

Deciphera Pharmaceuticals Inc is a biotechnology company, which develops and manufactures kinase-inhibiting drugs for the treatment of cancers and immunological diseases. It holds a diverse pipeline of drug candidates that includes three clinical-stage and two research-stage programs. Its lead drug candidate DCC-2618 is designed to inhibit the full spectrum of mutant or amplified KIT and Pdgfra kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. In addition, it is also developing two other clinical-stage drug candidates, DCC-3014 and Rebastinib. Geographically all the operations function through the region of the United States.

Deciphera Pharmaceuticals trades on the NASDAQ stock market under the symbol DCPH.

As of April 18, 2024, DCPH stock price declined to $14.23 with 737,283 million shares trading.

DCPH has a beta of 1.54, meaning it tends to be more sensitive to market movements. DCPH has a correlation of 0.18 to the broad based SPY ETF.

DCPH has a market cap of $1.15 billion. This is considered a Small Cap stock.

Last quarter Deciphera Pharmaceuticals reported $48 million in Revenue and -$.54 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.04.

In the last 3 years, DCPH stock traded as high as $48.27 and as low as $6.51.

The top ETF exchange traded funds that DCPH belongs to (by Net Assets): VTI, XBI, IWM, VXF, IBB.

DCPH has underperformed the market in the last year with a price return of -7.1% while the SPY ETF gained +22.2%. DCPH has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +2.4% and -6.0%, respectively, while the SPY returned +5.2% and -2.6%, respectively.

DCPH support price is $14.30 and resistance is $15.14 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DCPH stock will trade within this expected range on the day.